These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1541865)

  • 1. [The clinical significance of thrombin-antithrombin III complex (TAT) and fibrinogen and fibrin degradation products (FDP) levels in ovarian cancer].
    Sawaguchi K; Hojo T; Nozaki S; Yabushita H; Noguchi M; Nakanishi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jan; 44(1):73-8. PubMed ID: 1541865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prothrombin fragment F1+2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancer.
    Gadducci A; Marrai R; Baicchi U; Gagetti O; Facchini V; Genazzani AR
    Gynecol Oncol; 1996 May; 61(2):215-7. PubMed ID: 8626135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular marker for detecting hypercoagulable state].
    Magari Y; Mizunaga S; Ito M; Shibata T; Ito H
    Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A trial of setting of the reference intervals of thrombin antithrombin III complex and fibrin.fibrinogen degradation products in pregnant women].
    Shizuka R; Amagai H; Kojima J; Imaizumi S; Fukumura Y; Kobayashi I; Takagi T; Ibuki Y
    Rinsho Byori; 1994 Nov; 42(11):1194-8. PubMed ID: 7844893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of D-dimer in diagnosis of ovarian cancer].
    Kanayama N
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):485-8. PubMed ID: 2056222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
    Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
    Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Coagulation and fibrinolysis in pregnancy].
    Yuasa S; Ishizawa M; Yuki Y; Minoura T; Fujita N; Takahashi H; Yoshimura M; Yamamoto T; Okada H
    Rinsho Byori; 1992 Dec; 40(12):1287-91. PubMed ID: 1284915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of enzyme-linked immunosorbent assay to measure thrombin-antithrombin III complexes in horses with colic.
    Topper MJ; Prasse KW
    Am J Vet Res; 1996 Apr; 57(4):456-62. PubMed ID: 8712506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical application of laboratory diagnosis: leukemia and DIC].
    Deguchi K; Zhao LJ; Shirakawa S
    Rinsho Byori; 1991 Jul; 39(7):736-42. PubMed ID: 1833571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical usefulness of serum CA72-4 analysis in patients with ovarian cancer].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):585-9. PubMed ID: 2754289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alteration of serum levels of endotoxin, polymorphonuclear leukocyte elastase, and the molecular markers of the coagulation and fibrinolytic system in the patients with esophageal cancer and lung cancer before and following operation].
    Moriyama H; Hirata S; Kubo Y
    Rinsho Byori; 1995 Mar; 43(3):233-7. PubMed ID: 7745828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
    Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
    Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluctuation of thrombin-antithrombin III complex in patients with acute myocardial infarction: influence of low-dose heparin administration.
    Psuja P; Lewandowski K; Turowiecka Z; Zozulińska M; Tokarz A; Zawilska K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):229-36. PubMed ID: 1697824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the role of leukocytes in the activation of intravascular coagulation in septicemia].
    Okajima K; Uchiba M; Okabe H; Takatsuki K
    Rinsho Byori; 1990 Jul; 38(7):799-805. PubMed ID: 2205743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relation between blood coagulability and prognosis in patients with ovarian cancer].
    Sawaguchi K; Narumiya H; Yabushita H; Noguchi M; Nakanishi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Apr; 42(4):313-9. PubMed ID: 2358716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is quantitative determination of fibrin(ogen) degradation products and thrombin-antithrombin III complexes useful to diagnose deep venous thrombosis in outpatients?
    van Bergen PF; Knot EA; Jonker JJ; de Boer AC; de Maat MP
    Thromb Haemost; 1989 Dec; 62(4):1043-5. PubMed ID: 2694421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laboratory diagnosis of left atrial thrombi in patients with mitral stenosis].
    Hayashi I
    Fukuoka Igaku Zasshi; 1991 Nov; 82(11):550-61. PubMed ID: 1774012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of factors of coagulation and fibrinolysis in progression of lung cancer].
    Nagayama M; Tachibana A; Hayakawa H; Sato A
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):180-5. PubMed ID: 8390588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors].
    Shimizu Y; Akagaki E; Hirota K; Kono M; Miura S; Okudaira Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2813-20. PubMed ID: 3866801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.